1. Home
  2. AQMS vs LNAI Comparison

AQMS vs LNAI Comparison

Compare AQMS & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$3.20

Market Cap

12.8M

Sector

Industrials

ML Signal

HOLD

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

HOLD

Current Price

$3.89

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQMS
LNAI
Founded
2014
N/A
Country
United States
United States
Employees
N/A
29
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
11.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
AQMS
LNAI
Price
$3.20
$3.89
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
103.6K
721.7K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$600.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.15
52 Week High
$39.37
$5.02

Technical Indicators

Market Signals
Indicator
AQMS
LNAI
Relative Strength Index (RSI) 39.65 75.84
Support Level $2.51 $0.30
Resistance Level $4.36 N/A
Average True Range (ATR) 0.32 0.39
MACD -0.01 0.06
Stochastic Oscillator 45.61 55.23

Price Performance

Historical Comparison
AQMS
LNAI

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: